Legend Biotech Files 6-K, Confirms 20-F Reporting
Ticker: LEGN · Form: 6-K · Filed: Aug 18, 2025 · CIK: 1801198
| Field | Detail |
|---|---|
| Company | Legend Biotech Corp (LEGN) |
| Form Type | 6-K |
| Filed Date | Aug 18, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $500,000, $1 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, reporting-status, foreign-private-issuer
TL;DR
Legend Biotech filed a routine 6-K, confirming it's a foreign private issuer using Form 20-F.
AI Summary
Legend Biotech Corporation filed a Form 6-K on August 18, 2025. This report is for a foreign private issuer and indicates that the company files its annual reports under Form 20-F. The filing does not contain specific financial figures or operational updates beyond its classification and reporting status.
Why It Matters
This filing confirms Legend Biotech's status as a foreign private issuer and its adherence to SEC reporting requirements, which is standard for companies of its nature.
Risk Assessment
Risk Level: low — This filing is a routine administrative report and does not contain material non-public information that would typically impact risk.
Key Players & Entities
- Legend Biotech Corporation (company) — Filer of the report
- August 18, 2025 (date) — Date of the report
- Form 6-K (document) — Type of SEC filing
- Form 20-F (document) — Annual report form used by the company
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. It is used to furnish information which the issuer makes or is required to make public pursuant to the laws of its home country, or which it furnishes or makes public to its security holders.
What does it mean that Legend Biotech files under Form 20-F?
Filing under Form 20-F indicates that Legend Biotech is a foreign private issuer and files its annual reports on this form, which is tailored for foreign companies.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is August 18, 2025.
Does this filing contain specific financial results or operational updates?
No, this particular Form 6-K filing does not appear to contain specific financial results or detailed operational updates. It primarily serves to confirm the company's reporting status.
What is the principal executive office address for Legend Biotech Corporation?
The principal executive office address for Legend Biotech Corporation is 2101 Cottontail Lane, Somerset, New Jersey 08873.
Filing Stats: 1,301 words · 5 min read · ~4 pages · Grade level 11.9 · Accepted 2025-08-18 08:00:21
Key Financial Figures
- $500,000 — ent, Mr. Santos's annual base salary is $500,000 and Mr. Santos is eligible for a discre
- $1 m — value target anticipated to be at least $1 million, with the actual target amount to
Filing Documents
- f6k_081725.htm (6-K) — 14KB
- exh_991.htm (EX-99.1) — 7KB
- 0001171843-25-005462.txt ( ) — 22KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Legend Biotech Corporation (Registrant) Date: August 18, 2025 /s/ Ying Huang Ying Huang, Ph.D. Chief Executive Officer